Skip to main content

Table 1 Subject demographics

From: Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants

Case no.

Clinical Dx

Primary Neuropathological Dx

MAPT variant

Age/Sex

Symptom duration (yr)

PMI (hr)

Thal phase

Braak stage

CERAD score

ADNC

CDR score

FTLD-tau/MAPT

1

bvFTD/PSP-RS

FTLD-tau/MAPT

IVS10 + 16 C > T

60/M

8

12.5

ND

1

absent

Low

2a

2

bvFTD

FTLD-tau/MAPT

IVS10 + 16 C > T

60/M

13

15.8

1

0

absent

Low

3b

3

bvFTD

FTLD-tau/MAPT

IVS10 + 16 C > T

63/F

17

19.7

1

0

absent

Low

3

4

bvFTD

FTLD-tau/MAPT

P301L

59/F

4

24.2

1

1

absent

Low

2

5

bvFTD

FTLD-tau/MAPT

P301L

75/M

9

8.6

1

2

absent

Low

3

6

bvFTD

FTLD-tau/MAPT

V337 M

68/F

13

18.0

0

1

absent

Not

3

7

PSP-RS

PSP

A152T

56/F

6

5.7

2

2

absent

Low

3

8

nfvPPA

CBD

A152T

63/M

10

> 48 h

1

3

absent

Low

1

Average

   

63

10

15

1

1

  

2.5

Sporadic bvFTD-PiD

1

bvFTD

PiD

None

60/F

6

15.1

2–3

1

moderate

Low

3c

2

bvFTD

PiD

None

57/M

6

21.7

0

0

absent

Not

2d

3

bvFTD

PiD

None

70/M

10

10.2

2

0

moderate

Low

n/a

4

bvFTD

PiD

None

72/M

9

24.3

0

0

absent

Not

3

5

bvFTD

PiD

None

69/F

13

6.3

0

2

absent

Not

3

6

bvFTD

PiD

None

76/F

13

25.5

0

0

absent

Not

3

7

bvFTD

PiD

None

57/M

13

12.4

1

1

absent

Low

3

Average

   

66

10

17

1

1

  

2.8

  1. aantemortem, 3 months prior to death, bantemortem, 20 months prior to death, cantemortem, 18 months prior to death, dantemortem, 7 months prior to death, diagnosis (Dx), behvaioral variant FTD (bvFTD), progressive supranuclear palsy-Richardson syndrome (PSP-RS), nonfluent variant primary progressive aphasia (nfvPPA), corticobasal degeneration (CBD), Pick’s disease (PiD), Postmortem interval (PMI)